HomeRapid Medical

Rapid Medical

TIGER Trial Demonstrates High Safety and Efficacy for World’s First Adjustable Thrombectomy Device

The first adjustable, fully visible stent retriever shows superiority over conventional stent retrievers in a multicenter trial. The late-breaking results were recently presented at the International Stroke Conference and published online in the journal Stroke.

First Patient Enrolled to the TIGER Pivotal Clinical Study

5/16/18: "We are pleased to have enrolled the first patients and to have a leadership role in the TIGER study. Stentrievers are now the gold standard for treating ischemic stroke, and TIGERTRIEVER is a new generation stentriever. Its unique design will hopefully show that it addresses the limitations of current devices and will improve patient outcomes," stated Dr. Rishi Gupta.